japanese l glutathione CF Reduced 500mg Tablets – 30 Veg Tablets REDUCE WRINKLES Glutathione (Reduced) (100mg) Japanese Reduced L-Glutathione Effervescent Tablets

Rowe Price International Bond Fund (USD Hedged) - Investor Class 1290 Retirement 2020 Fund Class T 1290 Retirement 2020 Fund Class I 1290 Retirement 2020 Fund Class R 1290 Retirement 2025 Fund Class A 1290 Retirement 2025 Fund Class T 1290 Retirement 2025 Fund Class I 1290 Retirement 2025 Fund Class R 1290 Retirement 2030 Fund Class A 1290 Retirement 2030 Fund Class T 1290 Retirement 2030 Fund Class I 1290 Retirement 2030 Fund Class R 1290 Retirement 2035 Fund Class A 1290 Retirement 2035 Fund Class T 1290 Retirement 2035 Fund Class I 1290 Retirement 2035 Fund Class R 1290 Multi-Alternative Strategies Fund Class A 1290 Multi-Alternative Strategies Fund Class T 1290 Multi-Alternative Strategies Fund Class I 1290 Multi-Alternative Strategies Fund Class R 1290 Retirement 2040 Fund Class A 1290 Retirement 2040 Fund Class T 1290 Retirement 2040 Fund Class I 1290 Retirement 2040 Fund Class R 1290 Retirement 2045 Fund Class A 1290 Retirement 2045 Fund Class T 1290 Retirement 2045 Fund Class I 1290 Retirement 2045 Fund Class R 1290 Retirement 2050 Fund Class A New Perspective Fund - Class T 1290 Retirement 2050 Fund Class R 1290 Retirement 2055 Fund Class A 1290 Retirement 2055 Fund Class T 1290 Retirement 2055 Fund Class I 1290 Retirement 2055 Fund Class R 1290 Retirement 2060 Fund Class A 1290 Retirement 2060 Fund Class T Touchstone International Small Cap Fd Cl A Touchstone International Small Cap Fd Cl C TIAA-CREF Short-Term Bond Index Fund - Institutional Class Touchstone International Small Cap Fd Inst Cl Touchstone International Small Cap Fd Cl Y Dupree Mutual Funds Tennessee Tax-Free Income Series 1290 Global Talents Fund Class R 1290 Diversified Bond Fund Class A 1290 Diversified Bond Fund Class T 1290 Diversified Bond Fund Class I 1290 Diversified Bond Fund Class R 1290 GAMCO Small/Mid Cap Value Fund Class A 1290 GAMCO Small/Mid Cap Value Fund Class T 1290 DoubleLine Dynamic Allocation Fund Class I 1290 GAMCO Small/Mid Cap Value Fund Class I 1290 GAMCO Small/Mid Cap Value Fund Class R 1290 Retirement 2050 Fund Class T TIAA-CREF Social Choice Low Carbon Equity Fund - Institutional Class New World Fund 1290 Retirement 2050 Fund Class I 1290 DoubleLine Dynamic Allocation Fund Class A 1290 DoubleLine Dynamic Allocation Fund T 1290 Retirement 2060 Fund Class I 1290 Retirement 2060 Fund Class R 1290 Global Talents Fund Class A 1290 Global Talents Fund Class T 1290 Global Talents Fund Class I Thornburg New York Intermediate Municipal Fund Cl I 1290 DoubleLine Dynamic Allocation Fund Class R 1290 Low Volatility Global Equity Fund Class A 1290 Low Volatility Global Equity Fund Class T 1290 Low Volatility Global Equity Fund Class I 1290 Low Volatility Global Equity Fund Class R Federated Treasury Obligations Fund- AS Shares Touchstone Active Bond Fund Class A Touchstone Active Bond Fund Institutional Class Touchstone Active Bond Fund Class Y Tocqueville Fund Federated Treasury Obligations Fd Cap Shs Touchstone Active Bond Fund Class C Touchstone Mid Cap Growth Fund Class C Touchstone Ohio Tax-Free Bond Fd Class A Touchstone Ohio Tax-Free Bond Fund Class C Touchstone Ohio Tax Free Bond Fund Institutional Class Touchstone Ohio Tax Free Bond Fund Class Y Touchstone International Equity Fund Institutional Class Federated Treasury Obligations Fund Insti Shs DWS RREEF Global Infrastructure Fund - Class C DWS RREEF Global Infrastructure Fund - Class Inst DWS RREEF Global Infrastructure Fund - Class A DWS RREEF Global Infrastructure Fund - Class S DWS RREEF Global Infrastructure Fund - Class T DWS RREEF Global Infrastructure Fund - Class R6 Target 2050 Fund - I Class ADT 1957 Transformers Opportunities Portfolio Series 2019-2Q ADT 1972 Transformers Opportunities Portfolio Series 2019-3Q ADT 1992 Transformers Opportunities Portfolio Series 2020-1Q ADT 2008 Transformers Opportunities Portfolio Series 2020-2Q Tortoise Energy Evolution Fund Class C The Tocqueville Phoenix Fund Tortoise Energy Evolution Fund Institutional Class Tocqueville Opportunity Fd Cl A Tortoise Energy Evolution Fund Class A Tortoise MLP & Pipeline Fd C Cl Target 2010 Fund - I Class Tortoise MLP & Pipeline Fund Institutional Class Tortoise MLP & Pipeline Fund Class A Torray Fund Federated Treasury Obligations Fd Svc Shs Transamerica Mid Cap Value Opportunities Class R4 Transamerica Mid Cap Value Opportunities Class R Transamerica Mid Cap Value Opportunities Class I3 Federated Treasury Obligations Fund Trust Shs American Beacon Tocqueville International Value Fund - Institutional Class American Beacon Tocqueville International Value Fund - Y Class Towpath Focus Fund Timothy Plan Israel Common Values Fd Cl A Shs American Funds Preservation Portfolio - Class 529-T Test Mutual Fund 5 - PICE PGIM Core Bond Fund Class A PGIM Core Bond Fund Class C Timothy Plan Israel Common Values Fd Cl C Shs PGIM Core Bond Fund Class R6 PGIM Core Bond Fund Class R BlackRock Liquidity Funds TempCash - Capital Timothy Plan Defensive Strategies Fund Class A Timothy Plan Defensive Strategies Fund Class C Timothy Plan Defensive Strategies Fund - Class I Timothy Plan Fixed Income Fund - Class I STIT Treasury Portfolio Private Investment Class American Funds Global Growth Portfolio - Class T Target 2035 Fund - I Class American Funds Growth Portfolio - Class 529-T Timothy Plan High-Yield Fund Class A Timothy Plan High-Yield Fund Class C Timothy Plan High Yield Bond Fund - Class I Timothy Plan International Fund Class A Timothy Plan International Fund Class C Timothy Plan International Fund - Class I TIAA-CREF Lifecycle Retirement Income Fund Prem Templeton Global Bond Fund Class A TIAA-CREF Quant International Small-Cap Equity Fund - Premier Class State Street Insti Treasury Plus Fund Institutional Class T

Immunity Boost (Vitamin C + B-Complex + Glutathione): Reinforces immune defenses and may shorten the length and severity of illnesses

The cutoff values were selected at the most appropriate sensitivity and specificity

The agency has stated that 'research use only' labelling does not, on its own, exempt a product from regulatory requirements when it is sold or marketed in ways that imply human use

Conclusion DILI poses a significant clinical threat due to its potential for causing acute liver failure and associated mortality